I’m a 65-year-old male. On my recent semiannual checkup, my labs showed an AST level of 53 U/L and an ALT level of 62 U/L. I ...

Cirrhosis progresses in stages, from a compensated phase with few symptoms to a decompensated phase with serious ...

Panelists discuss how immunoglobulin A (IgA) nephropathy significantly impacts patients’ quality of life through chronic symptoms, treatment burden, psychological effects, and the looming threat of ...

A protein that stops cells from dividing in response to damage or stress could be a new biomarker or therapeutic target for ...

Auto-brewery syndrome produces symptoms of intoxication when ethanol produced by dysregulated gut microbiota exceeds the capacity of the liver to metabolize it.

Patients with LVV and IBD present with distinct clinical characteristics, including earlier onset and more severe vascular involvement.

SUNRISE-PD evaluating the Company’s anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson’s disease who have not been treated with carbidopa/l ...

An AI-based algorithm may help detect chronic liver disease using images from standard echocardiography, according to study ...

Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3 for patients with MASH cirrhosis and portal hypertension, today announced that it will attend the ...

About the expert Adrienna Jirik, MD, is a board-certified gastroenterologist at Cleveland Clinic, where she has been providing care since 2016. She completed advanced fellowships in ...

Learn how nonalcoholic fatty liver disease develops, its warning signs, and the steps to help safeguard the liver.

A meta-analysis of recent studies found a global steatotic liver disease prevalence of 37.5%. ( Clinical Gastroenterology and ...